Effectiveness of self-managed abortion during the COVID-19 pandemic: Results from a pooled analysis of two prospective, observational cohort studies in Nigeria.


Journal

PLOS global public health
ISSN: 2767-3375
Titre abrégé: PLOS Glob Public Health
Pays: United States
ID NLM: 9918283779606676

Informations de publication

Date de publication:
2022
Historique:
received: 04 05 2022
accepted: 22 09 2022
entrez: 24 3 2023
pubmed: 25 3 2023
medline: 25 3 2023
Statut: epublish

Résumé

Globally, restrictions imposed by the COVID-19 pandemic altered access to clinical abortion care, as well as people's ability to access abortion medications on their own. When clinical care is inaccessible, or when self-care is preferred, people use pills on their own, without clinical supervision, to end their pregnancies-a practice known as "self-managed" abortion. Little is known about experiences of self-managed abortion during the COVID-19 pandemic. The aim of this study was to measure experiences of self-managed abortion, including abortion completion, prior to and during the COVID-19 pandemic in Nigeria. Between October 2019-September 2020, we recruited callers to a safe abortion accompaniment group that provides information on self-managed abortion in Nigeria. Participants completed a baseline phone survey, and two follow-up phone surveys. Primary outcomes included burdens experienced prior to versus during the pandemic, and abortion completion. We calculated frequencies and percentages overall and by time period and compared outcomes across time periods using t-tests, Chi-squared tests, tests of proportion, and Mantel-Haenszel adjusted odds ratios. Overall, 807 participants were included in these analyses. Participants enrolled during the COVID-19 pandemic were more likely to report needing to borrow money (47.9% vs 29.4%) and find lodging outside the home (15.5% vs 3.2%) for their self-managed abortion than were those enrolled prior to the pandemic. Participants reported COVID-19 related difficulties most frequently during the earliest and strictest period of the lockdowns, particularly in obtaining and taking pills (32.4%), and comfort seeking healthcare (12.2%). Nearly all participants (95%) reported a complete abortion at last follow-up. Results from this study underscore the challenges Nigerians faced during the COVID-19 pandemic in self-managing their abortions, and also the essential role that a safe abortion hotline played in expanding access to safe abortion during a time when the formal healthcare system was less accessible and higher-risk.

Identifiants

pubmed: 36962640
doi: 10.1371/journal.pgph.0001139
pii: PGPH-D-22-00739
pmc: PMC10022159
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e0001139

Informations de copyright

Copyright: © 2022 Egwuatu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Stud Fam Plann. 2021 Jun;52(2):217-237
pubmed: 34043236
Int J Health Plann Manage. 2021 Jan;36(1):13-17
pubmed: 32857892
Lancet Glob Health. 2022 Jan;10(1):e105-e113
pubmed: 34801131
Sex Reprod Health Matters. 2022 Dec;30(1):2079808
pubmed: 35713531
Lancet. 2020 Aug 1;396(10247):301-302
pubmed: 32738942
BMJ Glob Health. 2020 Jan 7;5(1):e001814
pubmed: 32133166
Reprod Health. 2021 Nov 27;18(1):240
pubmed: 34838089
Front Glob Womens Health. 2022 Aug 17;3:899662
pubmed: 36060610
PLoS One. 2022 Feb 7;17(2):e0263072
pubmed: 35130269
Reprod Health. 2020 Oct 27;17(1):164
pubmed: 33109230
BMJ Sex Reprod Health. 2022 Jan;48(e1):e44-e52
pubmed: 33972396
Int Perspect Sex Reprod Health. 2015 Dec;41(4):170-81
pubmed: 26871725
BMJ Open. 2020 May 5;10(5):e034670
pubmed: 32376752
Reprod Health. 2021 Aug 4;18(1):166
pubmed: 34348757
BMJ Open. 2020 Nov 19;10(11):e036800
pubmed: 33444174
Best Pract Res Clin Obstet Gynaecol. 2020 Feb;63:87-110
pubmed: 31859163

Auteurs

Ijeoma Egwuatu (I)

Generation Initiative for Women and Youth, Lagos, Lagos State, Nigeria.

Sybil Nmezi (S)

Generation Initiative for Women and Youth, Lagos, Lagos State, Nigeria.

Ruvani Jayaweera (R)

Ibis Reproductive Health, Oakland, California, United States of America.

Relebohile Motana (R)

Ibis Reproductive Health, Houghton, Johannesburg, South Africa.

Belén Grosso (B)

La Revuelta Colectiva Feminista, Neuquén, Argentina.

Ika Ayu Kristianingrum (IA)

Samsara, Java, Indonesia.

Ruth Zurbriggen (R)

La Revuelta Colectiva Feminista, Neuquén, Argentina.

Chiara Bercu (C)

Ibis Reproductive Health, Oakland, California, United States of America.

Caitlin Gerdts (C)

Ibis Reproductive Health, Oakland, California, United States of America.

Heidi Moseson (H)

Ibis Reproductive Health, Oakland, California, United States of America.

Classifications MeSH